Clinical Trials
25 trialsTurkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
INSTIN
Institut National de la Santé Et de la Recherche Médicale, France
TRUS
Ankara Etlik City Hospital
ARPC-MRI
East and North Hertfordshire NHS Trust
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
PCa_LS
Azienda USL Reggio Emilia - IRCCS
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
Anhui Provincial Hospital
HIFU-PRO
Turku University Hospital
ERUP
Hull University Teaching Hospitals NHS Trust
Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy
Mersin Training and Research Hospital
Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer
Ankara Etlik City Hospital
PCa_Ex
Azienda USL Reggio Emilia - IRCCS
PROSTAGE
Turku University Hospital
Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided Biopsy
Assaf-Harofeh Medical Center
Explaining the Invisible Using the PEARL System
Hull University Teaching Hospitals NHS Trust
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)
Austin Health
Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection
Bagcilar Training and Research Hospital
Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?
Kronoberg County Council
Multi-IMPROD
Turku University Hospital
PROMANEG
Turku University Hospital
Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy
Instituto Mexicano del Seguro Social
Flucipro
Turku University Hospital
IMPROD
Turku University Hospital
PallRad1
Sorlandet Hospital HF
Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Hospital Authority, Hong Kong